Abstract
Exosomes show promise as next-generation therapy for osteoarthritis (OA) due to their ability to modulate inflammation and cartilage synthesis. Recent advances in the engineering of exosomes have enhanced their targeted therapeutic potential for OA.
Funding Information
  • National Institutes of Health (R01AR075121)
  • National Institute of Biomedical Imaging and Bioengineering (R21EB028385)
  • National Science Foundation (2141841)

This publication has 169 references indexed in Scilit: